RHEBP1 and neoplasm: The enhanced apoptosis of Rheb1Δ/Δ LSCs was further confirmed based on the observation that GFP+ cells and LSCs showed reduced p-4E-BP1, indicating the induction of apoptosis in tumor cells [56] and suggesting that Rheb1 might be a potential drug target for LSCs.